HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bone marrow metastasis of angiosarcoma.

Abstract
We report a rare finding of bone marrow metastasis from an angiosarcoma. The patient was a 36-year-old man who initially presented with a high-grade angiosarcoma of the spleen and was treated with splenectomy and chemotherapy. He developed leukoerythroblastic anemia three years after splenectomy. Bone marrow biopsy revealed extensive infiltrate by angiosarcoma with typical features of spindle tumor cells and anastomosing vascular channels. The immunohistochemistry showed tumor cells positive for the endothelial markers of CD31, CD34, and von Willebrand factor. Angiosarcomas are rare and aggressive tumors. Although metastases occur commonly, bone marrow findings have been rarely documented. We have found in the literature two other cases of bone marrow metastasis of angiosarcoma, and all these patients had a primary tumor of the spleen. It would seem that splenic angiosarcomas have a virtually unique propensity for infiltration in the bone marrow.
AuthorsChen Wang, Rola Rabah, Martin Blackstein, Robert H Riddell
JournalPathology, research and practice (Pathol Res Pract) Vol. 200 Issue 7-8 Pg. 551-5 ( 2004) ISSN: 0344-0338 [Print] Germany
PMID15462503 (Publication Type: Case Reports, Journal Article, Review)
Chemical References
  • Antigens, CD34
  • Platelet Endothelial Cell Adhesion Molecule-1
  • von Willebrand Factor
Topics
  • Adult
  • Antigens, CD34 (analysis)
  • Biopsy
  • Bone Marrow Neoplasms (chemistry, pathology, secondary)
  • Hemangiosarcoma (chemistry, pathology, secondary)
  • Humans
  • Immunohistochemistry
  • Male
  • Platelet Endothelial Cell Adhesion Molecule-1 (analysis)
  • Splenic Neoplasms (pathology)
  • von Willebrand Factor (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: